CVR - Coronavirus Vaccines R&D Roadmap

scientist holding vial

Our Work

The Vaccine Integrity Project delivers transparent, science-based vaccine information by rapidly countering inaccurate or misleading information, synthesizing evidence, and translating research for decision-making.

Project Overview

CIDRAP's Vaccine Integrity Project is an initiative dedicated to providing trusted, science-based information for informed vaccine choices.

The Vaccine Integrity Project focuses on: 

Rapidly responding. In response to misleading and inaccurate claims, the Vaccine Integrity Project monitors and addresses inaccurate vaccine- and public health-related information in real time.

Developing and disseminating the evidence base for immunization recommendations and clinical consideration.  Engaging with health care providers, the public health community, and medical societies, the Vaccine Integrity Project conducts comprehensive reviews of scientific evidence to inform vaccine recommendations.

Fostering continued collaboration and visibility. The scale and complexity of the challenges demand ongoing collaboration and coordinated action across the vaccine ecosystem. The Vaccine Integrity Project regularly convenes to support alignment and help prioritize and address emerging issues in real time. 

Research

Developing Evidence Reviews

Obtaining, reviewing, and synthesizing relevant evidence related to the role of vaccines in protecting health.

people meeting

Convening

Engaging with clinicians, professional societies, policymakers, media, influencers, and the public on vaccine-relevant evidence, information and policy; enhancing collaboration, visibility, and synergies by convening a wide variety of organizations to improve coordination and communication, and address emerging issues.

looking at laptop

Communicating

Translating research into accessible formats (fact sheets, reports, briefings, visual tools, etc) for broad dissemination to a range of audiences; monitoring the information environment with the goal of providing rapid-response communication around emerging vaccine-related developments.